National Cancer Centre's Ravindran Kanesvaran on future of cancer care, treatment costs

Channel News Asia 7 April 2025 

Report on Singapore’s efforts to advance cancer care by training healthcare staff overseas and studying cell therapies. Dr Ravindran Kanesvaran from NCCS highlighted a sharp rise in cancer among those aged 50 and below, prompting tailored programmes for seniors and a push to improve access to costly emerging treatments through multi-sector collaboration.

He also highlighted a 90% increase in cancer cases among those aged 50 and below from 1988–1992 to 2018–2022, with a 112% increase among females. He attributed the trend to lifestyle, environmental, and genetic factors, noting that many causes remain unclear.

Prof Ravindran Kanesvaran is also Co-Director of STCC.